THE TOWER
Eye on the Spine
by Avi Jorisch
October 2, 2018

Medtronic, an Irish-American medical device company, announced last Friday that it was purchasing Israel’s Mazor Robotics for a hefty $1.64 billion, the biggest exit ever for an Israeli biotech company. Mazor’s signature piece of technology, a robotic-assisted procedure, represents the future gold standard of spine surgery, which is now poised to be executed globally. Israeli innovations are improving the lives of millions of Americans and other people around the world, and this technology’s proven track record should encourage more American hospitals to adopt it. READ MORE